Motivación y Neurotransmisores en Remeros
Correlatos Psicobiológicos de la Motivación de Logro y Respuestas de Neurotransmisores al Ejercicio en Remeros de Élite
The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.
The main questions this study aims to answer are:
Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?
Participants will:
Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.
Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.
Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).
This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.
Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.
After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.
The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.
Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.
Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polonia, 61-871
- Poznań University of Physical Education
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.
Descripción
Inclusion Criteria:
National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing
Exclusion Criteria:
Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: RETROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Rowers
The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training. |
Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes in serum Cortisol levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Cortisol serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Testosterone levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Testosterone serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Dopamin levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Dopamin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Serotonin levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Serotonin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Beta-endorphin levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Beta-endorphin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum anandamide (AEA) levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of anandamide (AEA) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes in Testosterone-to-cortisol ratio (T:C)
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in TSerotonin-to-dopamine ratio (S:D)
Periodo de tiempo: Before exercise, immediately after, and 1 hour after recovery
|
Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Achievement Motivation (LMI score)
Periodo de tiempo: Before exercise (baseline)
|
Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles. |
Before exercise (baseline)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- LMI60002023
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .